US Broker Ratings

GRAIL, Inc. (GRAL) Stock Analysis: Potential 21.88% Upside Beckons Investors

GRAIL, Inc. (NASDAQ: GRAL), a pioneering company in the healthcare sector, is making waves with its innovative approach to cancer detection. Headquartered in Menlo Park, California,..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 187% Potential Upside in Biotech Innovation

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is capturing investor attention with a compelling growth narrative in the biotech sector. Specializing in the discovery and development of therapies..

Perrigo Company plc (PRGO) Investor Outlook: Exploring a 34% Potential Upside in the Healthcare Sector

Perrigo Company plc (NYSE: PRGO) stands as a prominent player in the healthcare sector, primarily focusing on over-the-counter health and wellness solutions. With a market capitalization..

Liquidia Corporation (LQDA) Stock Analysis: A 55% Upside Potential Amid Biotech Innovation

Liquidia Corporation (NASDAQ: LQDA) is a compelling player in the biotechnology sector, offering promising growth prospects driven by its innovative approach to addressing unmet medical needs...

Select Medical Holdings Corp (SEM) Stock Analysis: Unpacking a 53% Potential Upside for Investors

Select Medical Holdings Corp (NYSE: SEM) is making waves in the healthcare sector, currently trading at $11.97 with a market capitalization of $1.48 billion. With its..

Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring 22.55% Potential Upside with a Focus on Strategic Diversification

Bausch Health Companies Inc. (NYSE: BHC), a diversified healthcare giant with a robust portfolio in specialty pharmaceuticals and medical devices, is capturing investor attention with a..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Assessing Healthcare Sector Prospects Amid a 3.49% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, operates across the United States, focusing on senior living communities. With its diversified..

CG Oncology, Inc. (CGON) Stock Analysis: 117.71% Upside Potential Amidst High Analyst Confidence

CG Oncology, Inc. (NASDAQ: CGON) is capturing the attention of the investment community with a striking potential upside of 117.71%, as highlighted by the latest analyst..

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth with an 11.9% Revenue Surge

Warby Parker Inc. (NYSE: WRBY) has carved out a unique niche in the healthcare sector, specifically within the medical instruments and supplies industry, by revolutionizing how..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling a 56% Potential Upside

For investors with an eye on the healthcare industry, Schrodinger, Inc. (SDGR) presents itself as a compelling opportunity worth exploring. This New York-based company, operating in..

Apellis Pharmaceuticals (APLS) Stock Analysis: Exploring a 52.31% Upside Potential in the Biotech Sector

As investors navigate the tumultuous seas of the stock market, opportunities in the biotech sector often present themselves as high-risk, high-reward ventures. Apellis Pharmaceuticals, Inc. (NASDAQ:..

LivaNova PLC (LIVN) Stock Analysis: Unpacking a 43% Potential Upside in Medical Devices

LivaNova PLC (NASDAQ: LIVN), a prominent player in the healthcare sector, is attracting significant investor attention with a potential upside of 43.12%. This intriguing figure, coupled..

Concentra Group Holdings Parent (CON) Stock Analysis: A Promising Upside in Healthcare with 41.41% Potential

For investors keen on exploring opportunities within the healthcare sector, Concentra Group Holdings Parent (NYSE: CON) presents a compelling case. As a leader in occupational health..

Ligand Pharmaceuticals (LGND) Stock Analysis: A Promising Biotech with 7.84% Upside Potential

For investors with an eye on the biotechnology sector, Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) presents a compelling opportunity. The company, with a market cap of $2.61..

Zai Lab Limited (ZLAB) Stock Analysis: Unlocking a Potential 48.88% Upside in Biotechnology

Zai Lab Limited (NASDAQ: ZLAB), a dynamic player in the biotechnology sector, offers a promising yet complex investment opportunity. Headquartered in Pudong, China, Zai Lab is..

Merus N.V. (MRUS) Stock Analysis: Biotechnology Breakthroughs with 34% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based clinical-stage biotechnology company, is capturing investor attention with its promising pipeline of bispecific antibody therapeutics and a robust potential upside..

Viking Therapeutics, Inc. (VKTX) Stock Analysis: Exploring a 164.71% Upside Potential in Biotechnology

Viking Therapeutics, Inc. (NASDAQ: VKTX) has garnered significant attention in the biotechnology sector with its innovative approach to treating metabolic and endocrine disorders. Headquartered in San..

Galapagos NV (GLPG) Stock Analysis: Navigating Challenges with Biotech Innovation

Galapagos NV (NASDAQ: GLPG), a Belgium-based biotechnology firm, stands at the forefront of innovation in the healthcare sector, focusing primarily on oncology and immunology. With a..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: Exploring a 143% Potential Upside in Biotech Innovation

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) stands out in the healthcare sector, specifically in the biotechnology industry, with a focus on addressing rare endocrine diseases and endocrine-related..

Privia Health Group, Inc. (PRVA) Investor Outlook: Poised for 55% Upside with Strong Buy Ratings

Privia Health Group, Inc. (NASDAQ: PRVA), a leader in the healthcare sector, is rapidly gaining attention from investors. With its innovative approach to physician enablement and..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds